首页> 外文OA文献 >Single-Agent Pemetrexed or Sequential Pemetrexed/Gemcitabine as Front-Line Treatment of Advanced Non-small Cell Lung Cancer in Elderly Patients or Patients Ineligible for Platinum-Based Chemotherapy: A Multicenter, Randomized, Phase II Trial

【2h】

Single-Agent Pemetrexed or Sequential Pemetrexed/Gemcitabine as Front-Line Treatment of Advanced Non-small Cell Lung Cancer in Elderly Patients or Patients Ineligible for Platinum-Based Chemotherapy: A Multicenter, Randomized, Phase II Trial

机译：单药培美曲塞或序贯培美曲塞/吉西他滨作为老年患者或不适合铂类化疗的晚期非小细胞肺癌的一线治疗：多中心，随机，II期试验

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Gridelli Cesare; Kaukel Eckhard; Gregorc Vanessa; Migliorino Maria Rita; Müller Thomas R.; Manegold Christian; Favaretto Adolfo; Martoni Andrea; Caffo Orazio; Schmittel Alexander; Rossi Antonio; Russo Francesca; Peterson Patrick; Muñoz María; Reck Martin;
展开▼
作者单位

展开▼
年度 2007
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. A randomized phase II trial of pemetrexed/gemcitabine/bevacizumab or pemetrexed/carboplatin/bevacizumab in the first-line treatment of elderly patients with advanced non-small cell lung cancer. [J] . Spigel DR, Hainsworth JD, Shipley DL, Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer . 2012,第1期

机译：在一系列晚期非小细胞肺癌的老年患者的一线治疗中，培养基/吉西他滨/贝伐单抗或磷酸盐/卡铂/贝伐单抗的随机期II试验。
2. A randomized phase II trial of pemetrexed/gemcitabine/bevacizumab or pemetrexed/carboplatin/bevacizumab in the first-line treatment of elderly patients with advanced non-small cell lung cancer. [J] . Spigel DR, Hainsworth JD, Shipley DL, Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer . 2012,第1期

机译：在一系列晚期非小细胞肺癌的老年患者的一线治疗中，培养基/吉西他滨/贝伐单抗或磷酸盐/卡铂/贝伐单抗的随机期II试验。
3. A randomized phase II trial of pemetrexed/gemcitabine/bevacizumab or pemetrexed/carboplatin/bevacizumab in the first-line treatment of elderly patients with advanced non-small cell lung cancer. [J] . Spigel DR, Hainsworth JD, Shipley DL, Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer . 2012,第1期

机译：培美曲塞/吉西他滨/贝伐单抗或培美曲塞/卡铂/贝伐单抗在老年晚期非小细胞肺癌一线治疗中的随机II期试验。
4. Pemetrexed versus docetaxel single agent chemotherapy in chemotherapy-naive elderly patients with advanced non-small cell lung cancer [C] . Hua Xin, Zhenguo Han, Haibo Huang 2011 International Conference on Human Health and Biomedical Engineering . 2011

机译：培美曲塞与多西他赛单药化疗在未接受化疗的老年晚期非小细胞肺癌患者中的作用
5. Assessing the effectiveness of palliative chemotherapy for non-small cell lung cancer: A phase IV study of patients treated at Ontario's cancer centres [D] . Harrison, Lyndsay Dawn. 2012

机译：评估姑息化疗对非小细胞肺癌的有效性：在安大略省癌症中心接受治疗的患者的IV期研究
6. A phase II randomized trial evaluating gefitinib intercalated with pemetrexed/platinum chemotherapy or pemetrexed/platinum chemotherapy alone in unselected patients with advanced non-squamous non-small cell lung cancer [O] . Hui Yu, Jian Zhang, Xianghua Wu, 2014

机译：II期随机试验评估吉非替尼在未选出的晚期非鳞状非小细胞肺癌患者中单独接受培美曲塞/铂化疗或培美曲塞/铂化疗
7. A Randomized Phase II Trial of Pemetrexed/Gemcitabine/Bevacizumab or Pemetrexed/Carboplatin/Bevacizumab in the First-Line Treatment of Elderly Patients with Advanced Non-small Cell Lung Cancer [O] . Spigel David R., Hainsworth John D., Shipley Dianna L., 2012

机译：培美曲塞/吉西他滨/贝伐单抗或培美曲塞/卡铂/贝伐单抗在老年晚期非小细胞肺癌一线治疗中的随机II期试验

Single-Agent Pemetrexed or Sequential Pemetrexed/Gemcitabine as Front-Line Treatment of Advanced Non-small Cell Lung Cancer in Elderly Patients or Patients Ineligible for Platinum-Based Chemotherapy: A Multicenter, Randomized, Phase II Trial

著录项

相似文献

相关主题

期刊订阅